Verona Pharma (NASDAQ:VRNA) Price Target Raised to $93.00 at Wells Fargo & Company
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target boosted by Wells Fargo & Company from $74.00 to $93.00 in a research report report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Several other equities analysts have also commented on the stock. Roth Mkm started coverage on shares of […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target boosted by Wells Fargo & Company from $74.00 to $93.00 in a research report report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Several other equities analysts have also commented on the stock. Roth Mkm started coverage on shares of […]
